Ocumetics Reports Encouraging One-Month Postoperative Results

Executive Summary

• Ocumetrics Technology Corp. reported encouraging one‑month safety and visual performance results for the first Group 1 patients in its first‑in‑human study of the Ocumetrics Accommodating Intraocular Lens.
• All initial patients achieved functional distance vision of 20/40 or better without glasses; early near‑vision outcomes were also positive with no reported complications.
• The company highlighted a favorable safety profile and indicated that results are expected to improve as patients adapt and the trial progresses.

Key Details

• Study Design: First‑in‑human early feasibility study enrolling three patient groups; results presented for Group 1 after one month of follow‑up.
• Safety Findings: No intraocular lens‑related or surgery‑related adverse events reported in the first month.
• Surgical Technique: Procedures demonstrated ease of implantation of the Ocumetrics Lens into the natural lens compartment.
• Distance Vision Outcome: All Group 1 patients achieved 20/40 vision or better without corrective lenses.
• Near Vision Outlook: Early signs of near‑vision performance were observed; no complications noted, suggesting potential for functional near vision as adaptation continues.
• Management Commentary: President & CEO Dean Burns called the results a “historic milestone” and expressed confidence in continued momentum; CMO Dr. Doyle Stulting emphasized the excitement around achieving functional distance vision without glasses.
• Future Expectations: Company expects further improvement in visual outcomes over subsequent months as patients adapt and additional data are collected across all study groups.

Notable Quotes

“The safety profile and visual outcomes we’re seeing at this early stage are what we hoped for, and we are excited to continue building momentum as the clinical trial progresses.” – Dean Burns, President & CEO

“After one‑month, initial patients are already achieving functional distance vision of 20/40 or better without glasses and are showing encouraging signs of near vision performance with no complications.” – Dr. Doyle Stulting, Chief Medical Officer

“Our vision has always been to restore natural, seamless vision across all distances… Seeing these early clinical results come to life is incredibly inspiring.” – Dr. Garth Webb, Chief Scientist & Founder